Bifogade filer
Invitation to brain surgery simulation
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från FluoGuide A/S via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
2026-05-13 16:45:00
Copenhagen, Denmark, 13 May 2026 – FluoGuide A/S ("FluoGuide" or the "Company") is inviting investors to an event on Tuesday, June 2, 2026, where participants will get a close-up look at the company’s technology and clinical applications through a live brain surgery simulation using FluoGuide’s drug candidate FG001.
The attendees will have the opportunity to
- Do a live microscope-based simulation of brain surgery and experience the difference between surgery performed with and without FG001.
- Meet Dr Jane Skjøth-Rasmussen, MD, PhD. neurosurgeon at Rigshospitalet, who leads the Danish clinical trials in brain tumors with FG001 and has performed the highest number of surgeries using FG001 to date.
- Learn about the practical implications of FluoGuide’s: FDA Fast Track designation and IND (Investigational New Drug) clearance for the U.S. market.
- Gain insight into the clinical results for FG001 and upcoming milestones in aggressive brain cancer and head & neck cancer.
Time and Location
- Date: Tuesday, June 2, 2026
- Time: 16:30–18:00 CET
- Location: Titanhus, Titangade 9–13, 2200 Copenhagen.
The invitation (in Danish is enclosed). Registration is required by follow this link (https://fluoguide.com/event/fluoguide-event/)